Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
Cancer Antigen (CA) 19-9, Serum
Dilated cardiomyopathy
Endometriosis
Gamma Glutamyl Transferase (GGT)
Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
DNA Cell Cycle Analysis by Flow Cytometry
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test
ICD10
Access to
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
is restricted.
Sign up now
Loading...